Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Ubiquitin-Protein Ligases. Found 5 abstracts

Tahrir FG, Knezevic T, Gupta MK, Gordon J, Cheung JY, Feldman AM, Khalili K. Evidence for the Role of BAG3 in Mitochondrial Quality Control in Cardiomyocytes. Journal of cellular physiology. 2017 Apr;232(4):797-805.   PMCID: PMC5663276
Allen JE, Prabhu VV, Talekar M, van den Heuvel AP, Lim B, Dicker DT, Fritz JL, Beck A, El-Deiry WS. Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10. Cancer Res. 2015 Apr 15;75(8):1668-74.   PMCID: PMC4541796
Higuchi T, Flies DB, Marjon NA, Mantia-Smaldone G, Ronner L, Gimotty PA, Adams S. CTLA-4 blockade synergizes therapeutically with PARP-inhibition in BRCA1-deficient ovarian cancer. Cancer Immunol Res. 2015 Jul 02;3(11):1257-68.   PMCID: 4984269
Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, Ross EA, Yeung AT, Nicolas E, Tsichlis N, Li YS, Linehan WM, Howard S, Campbell KS, Godwin AK, Boman BM, Crowell JA, Kopelovich L, Knudson AG. Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther. 2004 Dec;3(12):1313-21.
Sudakin V, Yen TJ. Purification of the mitotic checkpoint complex, an inhibitor of the APC/C from HeLa cells. Methods in Molecular Biology. 2004 Jan;281:199-212.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Ubiquitin-Protein Ligases

Ubiquitin-Protein Ligases metabolism Antineoplastic Agents pathology therapeutic use genetics Kidney antagonists & inhibitors 141349-76-0 (mitotic spindle checkpoint protein MAD2) administration & dosage CTLA-4 Antigen Mice Calcium-Binding Proteins Oligonucleotide Array Sequence Analysis Antitumor Drug Screening Assays Mitochondrial Membrane Potential proteins for ubiquitin-mediated proteolysis Great efforts have been Inhibitor of Apoptosis Proteins Genetic Association Studies anaphase-promoting complex 31430-18-9 (Nocodazole) ai [Antagonists & Inhibitors] AB - The mitotic checkpoint prevents cells with unaligned T-Lymphocyte Subsets this checkpoint pathway These studies will ultimately lead to a inhibitor of the APC deficiency Proto-Oncogene Proteins c-bcl-2 Nude Mice Proteasome Inhibitors Signal Transducing Adaptor Proteins of HeLa cells Apoptosis Regulatory Proteins Heterozygote called mitotic checkpoint C from HeLa cells 0 (Carrier Proteins) Immunologic Cytotoxicity therapy better understanding of cell cycle defects and chromosome Sprague-Dawley Rats physiology Autophagy Drug Dose-Response Relationship Protein Transport Tumor Suppressor Proteins Germ-Line Mutation Carbonyl Cyanide m-Chlorophenyl Hydrazone complex (MCC) Our procedure is based on biochemical purification EC 6-3-2-19 (Ubiquitin-Protein Ligase Complexes) biosynthesis Energy Metabolism cyclosome (APC Preclinical Drug Evaluation cytology drug effects C inhibitory activity from extracts Immunologic Memory Cultured Cells Poly(ADP-ribose) Polymerase Inhibitors von Hippel-Lindau Disease made recently to identify and characterize the factors involved in and characterization of the APC Immunotherapy Lysosomes Combined Modality Therapy Mitochondrial Degradation Gene Expression Profiling Mitochondria pharmacology Epithelial Cells chromosomes from prematurely exiting mitosis by inhibiting the C) from targeting key methods HCT116 Cells Gene Knockdown Techniques Inbred C57BL Mice Monoclonal Antibodies Heterocyclic Compounds with 4 or More Rings EC 6-3-2-19 (Ubiquitin-Protein Ligases) Female Cultured Tumor Cells Neoplasm Drug Resistance Cardiac Myocytes Ovarian Neoplasms Apoptosis Neoplasm Transplantation immunology Von Hippel-Lindau Tumor Suppressor Protein Interferon-gamma EC 6-3-2-19 (anaphase-promoting complex) Biological Tumor Markers CASP8 and FADD-Like Apoptosis Regulating Protein instability We report here a protocol for purification of an 0 (Antineoplastic Agents) Hep G2 Cells Cell Line Small Molecule Libraries
Last updated on Friday, January 03, 2020